Activmend Pro

Arnica Montana, Hypericum Perforatum, Ledum Palustre, Rhus Toxicodendron, Ruta Graveolens

Cearna, Inc.
Human Otc Drug
NDC 76277-123

Activmend Pro also known as Arnica Montana, Hypericum Perforatum, Ledum Palustre, Rhus Toxicodendron, Ruta Graveolens is a human otc drug labeled by 'Cearna, Inc.'. National Drug Code (NDC) number for Activmend Pro is 76277-123. This drug is available in dosage form of Patch. The names of the active, medicinal ingredients in Activmend Pro drug includes Arnica Montana - 50 [hp_M]/g Hypericum Perforatum - 50 [hp_M]/g Ledum Palustre Twig - 50 [hp_M]/g Ruta Graveolens Flowering Top - 50 [hp_M]/g Toxicodendron Pubescens Leaf - 50 [hp_M]/g . The currest status of Activmend Pro drug is Active.

Drug Information:

Drug NDC:	76277-123
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Activmend Pro
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Arnica Montana, Hypericum Perforatum, Ledum Palustre, Rhus Toxicodendron, Ruta Graveolens
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Cearna, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Patch
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ARNICA MONTANA - 50 [hp_M]/g HYPERICUM PERFORATUM - 50 [hp_M]/g LEDUM PALUSTRE TWIG - 50 [hp_M]/g RUTA GRAVEOLENS FLOWERING TOP - 50 [hp_M]/g TOXICODENDRON PUBESCENS LEAF - 50 [hp_M]/g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	09 Feb, 2021
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	10 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Cearna, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	O80TY208ZW XK4IUX8MNB 877L01IZ0P N94C2U587S 6IO182RP7A
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
76277-123-32	1 PATCH in 1 POUCH (76277-123-32) / 113.4 g in 1 PATCH	09 Feb, 2021	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Activmend Pro

Arnica Montana & more..

Patch
Cearna, Inc.
NDC: 76277-123

Purpose:

Purpose purpose: arnica montana 50m...........................bruising, muscle strain hypericum perforatum 50m................pain ledum palustre 50m...........................swelling, pain rhus toxicodendron 50m....................sprains, strains, swelling, pain ruta graveolens 50m..........................strains

Product Elements:

Activmend pro arnica montana, hypericum perforatum, ledum palustre, rhus toxicodendron, ruta graveolens butyl acrylate/methyl methacrylate/methacrylic acid copolymer (18000 mw) methyl diethanolamine water hydroxyethyl cellulose, unspecified hypericum perforatum hypericum perforatum ledum palustre twig ledum palustre twig arnica montana arnica montana toxicodendron pubescens leaf toxicodendron pubescens leaf ruta graveolens flowering top ruta graveolens flowering top

Indications and Usage:

Uses for the reduction of swelling and pain associated with joint sprains, muscle strains, shin splints, dislocations, overuse injuries, and bruising.

Warnings:

Warnings warnings for external use on intact skin only use only as directed. do not bandage tightly. stop use and ask a doctor if condition worsens. do not use in the eyes, over open wounds, or if you have unexpected bleeding. if pregnant or breast-feeding, ask a health professional before use. do not use if you are allergic to any of this product's active or ingredients.

Do Not Use:

Dosage and Administration:

Directions directions: adults and children 12 years of age and over clean and dry affected area. remove patch from film. place healing pads on intact skin. wear one activmend patch up to 24 hours. children under 12 years of age - consult a doctor

Stop Use:

Stop use and ask a doctor âstop use and ask a doctor if condition worsens

Package Label Principal Display Panel:

Label

Further Questions:

Questions? questions: 1-855-255-mend (6363) or email: support@activmend.com

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.